Sunniva

SNNVF

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$3,921

Exchange

Other OTC

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 9, 2026 · filings through Sep 30, 2019

Share count rising — dilution

+3.6% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 30.7M (2015) → 31.8M (2018)

Sunniva Inc. is a Canadian cannabis company that grows and sells marijuana products for both medical and adult recreational use. Its main customers are medical patients, licensed distributors, and retail cannabis stores, primarily in Canada. The company operates licensed cannabis production facilities and focuses on producing dried flower, oils, and other cannabis-derived products.

Sunniva generates revenue by selling cannabis products wholesale to provincial distributors and directly through medical channels. It operates mainly in Canada, and with a market cap near zero, it is a very small player in a crowded industry. The cannabis sector in Canada has faced intense price competition and oversupply, which helps explain why Sunniva's operating losses are steep despite a reasonable gross margin. The biggest risk the company faces is simply surviving long enough to reach profitability, as ongoing cash burn and a difficult regulatory and pricing environment make that path uncertain.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+43.4% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

-147.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

↓ Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Runway

~0 months

$304,000 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Strong grower

Sunniva is growing revenue at 43% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

29.3%

Modest — 29.3% gross margin

Operating Margin

-133.2%

Losing money on operations — -133.2%

ROCE

-7.7%

Weak — -7.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+57.7%

Fast-growing sales (+57.7% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-193.8%

Burning cash (-193.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.73

Moderate — manageable debt (0.73)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial